Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 2,000 shares at $3.13 ($7K) on 2022-04-06, disclosed to the SEC on 2022-04-08.
Open-market purchase of $7k PCSA by Chief Business - Strategy Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.13 | 1,200 | $4K | 57.0% |
| 2 | $3.54 | 800 | $3K | 43.0% |
| Total | $3.29 avg | 2,000 | $7K | 100% |
| Filing → |
| PCSA | BUY | 2026-06-01 | $4K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $4K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $4K | — | Filing → |